<< NMT Medical announces favorable patent decision | Bill Clinton is recovering after undergoing successful quadruple bypass surgery >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski

University of Utah gets patent approval relating to methods of rapid nucleic acid amplification

Published on September 8, 2004 at 9:26 AM · No Comments

The U.S. Patent and Trademark Office has issued the University of Utah U.S. patent No. U.S. 6,787,338 (the '338 patent) relating to methods of rapid nucleic acid amplification.

The issuance of this patent reinforces the University's patent portfolio in the area of real-time nucleic acid amplification, quantification, and melting analysis.

The '338 patent is the most recent to join the portfolio of patents owned by the University of Utah, which includes U.S. patent No. 6,174,670 for monitoring nucleic acids with probes or dyes during or after amplification reactions such as the polymerase chain reaction (PCR), and U.S. patent No. 6,569,627 which relates to real-time PCR using certain dyes such as SYBR Green I. The '338 patent and other patents in the portfolio are exclusively licensed to Idaho Technology, Inc., a business in Salt Lake City, Utah.

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading